Early rituximab treatment is associated with increased and sustained remission in pemphigus patients: A retrospective cohort of 99 patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Early rituximab treatment is associated with increased and sustained remission in pemphigus patients: A retrospective cohort of 99 patients

Published:2022-03-04 Issue:5 Volume:35 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Nosrati Adi¹²,Mimouni Tomer²,Hodak Emmilia¹²,Gdalevich Michael³⁴,Oren‐Shabtai Meital¹²^ORCID,Levi Assi¹²,Mimouni Daniel¹²,Leshem Yael A.¹²

Affiliation:

1. Division of Dermatology Rabin Medical Center Petah Tiqva Israel

2. Sackler Faculty of Medicine Tel Aviv University Tel Aviv Israel

3. Israel Ministry of Health Beer Sheva Israel

4. Faculty of Health Sciences, Department of Health Systems Management Ben Gurion University of the Negev Beer Sheva Israel

Publisher

Hindawi Limited

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.15397

Reference24 articles.

1. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion

2. Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.

3. Cell Adhesion Molecules as Targets of Autoantibodies in Pemphigus and Pemphigoid, Bullous Diseases Due to Defective Epidermal Cell Adhesion

4. Rituximab in the Treatment of Pemphigus Vulgaris

5. THE RISKS OF SYSTEMIC CORTICOSTEROID USE

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pruritus Is Associated with an Increased Risk for the Diagnosis of Autoimmune Skin Blistering Diseases: A Propensity-Matched Global Study;Biomolecules;2023-03-06

2. Role of Rituximab in the Treatment of Pemphigus Vulgaris: Patient Selection and Acceptability;Patient Preference and Adherence;2022-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3